Integene International

Recent Finacing

Equity

Recent Raise

Undisclosed

Integene develops a platform combining proprietary gene modulation and autologous stem‑cell bioengineering for multifactorial tissue re‑engineering and combined gene/stem‑cell therapies targeting ischemic cardiovascular disease and diabetes complications.